Results 111 to 120 of about 2,887 (179)

Anti-inflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation

Кардиоваскулярная терапия и профилактика, 1970
Background: Experimental studies revealed pro-inflammatory properties of angiotensin II. We evaluated antiinflammatory effects of the angiotensin II subtype 1 receptor antagonist olmesartan medoxomil alone and in cotherapy with the HMG-CoA reductase ...
Danilo Fliser, Konrad Buchholz, Hermann Haller   +2 more
doaj  

Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action. [PDF]

Adv Pharm Bull, 2020
Arun JK, Vodeti R, Shrivastava B, Bakshi V.   +3 more
europepmc   +1 more source

Stability of Olmesartan Medoxomil Tablets in Unit-Dose Packaging With Metformin Hydrochloride Tablets. [PDF]

Cureus
Ohashi R, Yasunaga S, Ishimura A, Furuya T, Aizawa Y, Omori T, Kurita T, Nakajima T, Takizawa Y.   +8 more
europepmc   +1 more source

Host-Guest Interaction Study of Olmesartan Medoxomil with β-Cyclodextrin Derivatives. [PDF]

Molecules
Andor M, Temereancă C, Sbârcea L, Ledeți A, Man DE, Mornoș C, Ridichie A, Cîrcioban D, Vlase G, Barvinschi P, Caunii A, Văruţ RM, Trandafirescu CM, Buda V, Ledeți I, Rădulescu M.   +15 more
europepmc   +1 more source

Host-Guest Complexation of Olmesartan Medoxomil by Heptakis(2,6-di-O-methyl)-β-cyclodextrin: Compatibility Study with Excipients. [PDF]

Pharmaceutics
Man DE, Nițu ET, Temereancă C, Sbârcea L, Ledeți A, Ivan D, Ridichie A, Andor M, Jîjie AR, Barvinschi P, Rusu G, Văruţ RM, Ledeți I.   +12 more
europepmc   +1 more source

Olmesartan Medoxomil-Loaded Niosomal Gel for Buccal Delivery: Formulation, Optimization, and Ex Vivo Studies. [PDF]

Turk J Pharm Sci
Palei NN, Mohanta BC, Rajangam J, Guptha PM.   +3 more
europepmc   +1 more source

Acute quadruple extremity compartment syndrome due to angio-oedema after polypharmacy overdose including olmesartan medoxomil, telmisartan and vildagliptin. [PDF]

BMJ Case Rep
Kono Y, Takimoto K, Fujii M, Hayashi Y.
europepmc   +1 more source

Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice. [PDF]

Drug Des Devel Ther, 2019
Zhu Y, Li ZL, Ding A, Yang H, Zhu WP, Cui TX, Zhang HT, Zhang H.   +7 more
europepmc   +1 more source

Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation. [PDF]

Int J Nanomedicine, 2019
Albash R, Abdelbary AA, Refai H, El-Nabarawi MA.   +3 more
europepmc   +1 more source